Feature

Discoveries made possible by DNA

Courtney Chandler
Nov. 24, 2025

Nearly 70 years ago, James Watson and Francis Crick proposed the double-helix model of DNA, transforming how scientists understood heredity and launching the field of molecular biology. On November 6, Watson died in New York at age 97. Although a controversial figure, contributed to defining DNA structure and helped characterize the molecule that remains fundamental to understanding biology.

Now, genes and DNA are now closely linked in concept, but scientists in Watson and Crick’s era did not understand the chemical basis of inheritance. Watson and Crick suspected a molecule called DNA — which was first identified in the 1860s — could hold the answer. Earlier findings by Phoebus Levene and Erwin Chargaff revealed the basic chemical components of DNA and how they were arranged. Building on this work and drawing on crucial X-ray crystallography data from Maurice Wilkins and Rosalind Franklin some of which was shared without her consent, Watson and Crick built a physical model that revealed DNA’s double-helix structure. Although refinements have been made since their original published paper, the core model has endured. Watson, Crick and Wilkins were awarded the 1962 Nobel Prize in Physiology or Medicine for their work.

The discovery of the double helix answered key questions about how genetic information is encoded and faithfully copied. Its complementary strand structure explained how DNA can replicate with high fidelity, as each strand serves as a template for creating a new partner. The DNA sequence also hinted at how genes direct protein synthesis, although the full genetic code was not deciphered until more than a decade later. The breakthrough transformed the understanding of life at the molecular level and helped launch the field of molecular biology.

The double-helix model triggered a cascade of scientific breakthroughs, including the development of recombinant DNA technology. Advances in DNA sequencing have enabled scientists to map genes in detail, trace evolutionary relationships and uncover the molecular foundations of many diseases. These efforts culminated in the Human Genome Project, a landmark achievement that produced the first complete map of human genes.

DNA now sits at the center of modern science and medicine, powering technologies that allow more precise diagnostics and increasingly personalized medical care. New frontiers have emerged — gene editing is possible thanks to tools such as CRISPR–Cas9 and synthetic biology, which combines engineering and genetics, is being used to create new biological systems or redesign existing ones. Beyond healthcare, DNA-based tools support public-health surveillance, the development of more resilient crops and the monitoring of the genetic health of endangered species. These advances are built on the ability to read, interpret and rewrite DNA’s underlying code.

Although the double-helix model answered fundamental questions, many mysteries remain, from the roles of noncoding DNA to the complex layers of epigenetic modification and genome-wide regulatory networks. New tools and technology continue to expand what questions can be answered, ensuring that DNA research will fuel scientific innovation and inspire the next era of discovery.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Courtney Chandler

Courtney Chandler is a biochemist and microbiologist in Baltimore, Md., and a columnist for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Heat shock proteins as a promising breast cancer therapeutic
Journal News

Heat shock proteins as a promising breast cancer therapeutic

March 25, 2026

Researchers unveiled isoform-specific targets on heat shock protein 90 which may be beneficial in therapeutic development.

Optimized proteomic analysis of preserved biological tissue samples
Journal News

Optimized proteomic analysis of preserved biological tissue samples

March 25, 2026

Researchers have developed an optimized workflow for analyzing formalin-fixed paraffin-embedded tissue. This workflow provides an enhanced collection of unique proteins and phosphorylation sites for more detailed analysis of biological samples.

Blood proteomics reveals fungal infection signatures for faster diagnosis
Journal News

Blood proteomics reveals fungal infection signatures for faster diagnosis

March 24, 2026

Whole-blood proteomics identifies more than 3,000 host and 160 fungal proteins during cryptococcal infection, offering potential biomarkers for faster diagnosis and improved monitoring without invasive spinal taps.

When things get SAPpy: Novel insights into complement
Journal News

When things get SAPpy: Novel insights into complement

March 20, 2026

Researchers have defined interactions between an innate immune protein and two of its known binding partners. They identified potential areas of crosstalk between the two binding interactions.

Glutathione pathway implicated in rare disease
Journal News

Glutathione pathway implicated in rare disease

March 19, 2026

Researchers found that glutathione metabolism plays a central role in the pathogenesis of rare disease methylmalonic aciduria using a novel multiomics approach.

A p-value for proteins
Journal News

A p-value for proteins

March 18, 2026

Kyoto University researchers developed UniScore, a new tool that uses a target-decoy method to filter false positives in proteomic searches, helping scientists set thresholds and improve reliability when analyzing complex protein data.